 |
 |

Intraperitoneal Splenic AutotransplantationProtection Afforded in a Naturally Occurring Epidemic of Murine Mycoplasmosis
Charles D. Livingston, MD;
Barry A. Levine, MD;
Kenneth R. Sirinek, MD, PhD
Arch Surg. 1983;118(4):458-461.
Abstract
Intraperitoneal splenic autotransplantation is now a clinical reality. However, doubts remain as to complications that might develop when splenic tissue is placed in this site. We assessed the ability of an extraperitoneal (subcutaneous) site of autotransplantation to provide protection similar to that previously demonstrated by intraperitoneal splenic reimplantation. These effects were studied during a naturally occurring epidemic of murine respiratory mycoplasmosis. Intraperitoneal splenic transplants but not subcutaneous implants improved chances for survival during this infectious epidemic. The results suggest that a subcutaneous site for splenic autotransplantation is not clinically applicable.
(Arch Surg 1983;118:458-461)
Author Affiliations
From the Surgical Service, Audie L. Murphy Memorial Veterans Hospital (Dr Levine), and the Department of Surgery, University of Texas Health Science Center (Drs Livingston and Sirinek), San Antonio.
Footnotes
Accepted for publication Oct 19, 1982.
Read before the Sixth Annual Surgical Symposium of the Association of Veterans Administration Surgeons, Atlanta, May 14, 1982.
Reprint requests to Department of Surgery, University of Texas Health Science Center, 7703 Floyd Curl Dr, San Antonio, TX 78284 (Dr Sirinek).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Pneumococcal Clearance Function of the Intact Autotransplanted Spleen
Zhao et al.
Arch Surg 1995;130:946-950.
ABSTRACT
Transplant Site Affects Splenic T- and B-Cell Survival and Function
Livingston et al.
Arch Surg 1985;120:89-92.
ABSTRACT
|